Related Experiment Videos
Percutaneous transluminal angioplasty for renovascular hypertension
Archives of Disease in Childhood
|July 1, 1985
Insights
Percutaneous transluminal angioplasty effectively treated renovascular hypertension in children. This safe procedure normalized blood pressure in most patients, offering significant clinical improvement.
Area of Science:
- Pediatric Nephrology
- Interventional Cardiology
Background:
- Renovascular hypertension in children presents unique challenges.
- Identifying effective and safe treatment modalities is crucial.
Observation:
- Five pediatric patients with renovascular hypertension underwent angioplasty.
- Follow-up ranged from 12 to 32 months.
Findings:
- Blood pressure normalized in 80% of patients and improved in 20%.
- Angiographic and endocrinological markers showed improvement.
- No complications were reported during the follow-up period.
Implications:
- Percutaneous transluminal angioplasty is a safe and effective option for pediatric renovascular hypertension.
- This minimally invasive approach offers significant benefits for affected children.
Abstract:
Five children with renovascular hypertension were treated with percutaneous transluminal angioplasty, and followed for 12 to 32 months. Blood pressure fell to normal in four patients and improved in one. Angiographic and endocrinological improvements were associated with a fall in blood pressure and no complications were observed. Angioplasty is considered a safe, effective treatment for children with renovascular hypertension.